Polygenic risk scores (PRS) have shown promise in predicting disease susceptibility, but their accuracy varies across populations due to limited representation of non-European ancestries in genomic studies. While European-derived PRS demonstrate some transferability to Asian populations, optimizing these scores for specific populations remains crucial for improving risk prediction.